A new U.N. AIDS agency report says the sudden withdrawal of U.S. funding has caused a “systemic shock” to the global effort ...

In an interview with The News & Observer, Dr. Barton Haynes discusses the future of HIV vaccine development after HHS ...

In a report released on Thursday, the UN body in charge of fighting HIV/Aids does not single out the US, but says that ...

If approved, doravirine/islatravir would be the first two-drug HIV treatment regimen without an integrase inhibitor, ...

UN says if US funding for HIV programs is not replaced, millions more will die by 2029 ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

(Reuters) -Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized ...

The HIV pandemic still claims a life every minute. While progress has been made, there were 1.3 million new HIV infections ...

The Food and Drug Administration (FDA) has accepted the New Drug Application for doravirine/islatravir (DOR/ISL) for adults with virologically-suppressed HIV-1 infection.

The sudden withdrawal of US funding from HIV programmes around the world could undo decades of progress. This is according to ...

People living with HIV face unique oral health challenges that require special attention and care. The virus's impact on the ...